These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22051859)

  • 61. Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study.
    Lavigne JE; Shearer WT; Thompson B; Orav EJ; Starc TJ; Colan SD; Pignatelli R; O'Brien SE; Bezold L; LaRusa P; Easley KA; Cheng I; Duffy SA; Lipshultz SE;
    Cardiovasc Toxicol; 2004; 4(2):187-97. PubMed ID: 15371634
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017.
    Powis KM; Huo Y; Williams PL; Kacanek D; Jao J; Patel K; Seage GR; Van Dyke RB; Chadwick EG;
    JAMA Netw Open; 2019 Dec; 2(12):e1917669. PubMed ID: 31851347
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety of tenofovir during pregnancy: early growth outcomes and hematologic side effects in HIV-exposed uninfected infants.
    Seidel V; Weizsäcker K; Henrich W; Rancourt RC; Bührer C; Krüger R; Feiterna-Sperling C
    Eur J Pediatr; 2020 Jan; 179(1):99-109. PubMed ID: 31659467
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pre-treatment drug resistance and HIV-1 subtypes in infants from Argentina with and without exposure to antiretroviral drugs for prevention of mother-to-child transmission.
    Aulicino PC; Zapiola I; Kademian S; Valle MM; Fernandez Giuliano S; Toro R; Barbas G; Cañizal AM; Mayon P; Golemba MD; Ortiz de Zarate M; Corazza MS; Cudola A; Mecikovsky D; Bologna R; Mangano A; Sen L
    J Antimicrob Chemother; 2019 Mar; 74(3):722-730. PubMed ID: 30517632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants.
    Rovira N; Noguera-Julian A; Rives S; Berrueco R; Lahoz R; Fortuny C
    Eur J Pediatr; 2016 Jul; 175(7):1013-7. PubMed ID: 27165499
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era.
    Eckard AR; Kirk SE; Hagood NL
    Curr HIV/AIDS Rep; 2019 Dec; 16(6):492-500. PubMed ID: 31630334
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
    Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
    Sante; 1997; 7(2):115-25. PubMed ID: 9273118
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens.
    Balogun KA; Guzman Lenis MS; Papp E; Loutfy M; Yudin MH; MacGillivray J; Walmsley SL; Silverman M; Serghides L
    Clin Infect Dis; 2018 Jan; 66(3):420-427. PubMed ID: 29020282
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa.
    le Roux SM; Abrams EJ; Nguyen K; Myer L
    Trop Med Int Health; 2016 Jul; 21(7):829-45. PubMed ID: 27125333
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Infant outcomes after maternal antiretroviral exposure in resource-limited settings.
    Nielsen-Saines K; Komarow L; Cu-Uvin S; Jourdain G; Klingman KL; Shapiro DE; Mofenson L; Moran L; Campbell TB; Hitti J; Fiscus S; Currier J;
    Pediatrics; 2012 Jun; 129(6):e1525-32. PubMed ID: 22585772
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of antenatal antiretroviral drug exposure on the growth of children who are HIV-exposed uninfected: the national South African Prevention of Mother to Child Evaluation cohort study.
    Ramokolo V; Kuhn L; Lombard C; Jackson D; Goga AE
    BMC Infect Dis; 2022 Dec; 22(1):908. PubMed ID: 36474212
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
    Mnyani CN; McIntyre JA; Myer L
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials.
    Chigwedere P; Seage GR; Lee TH; Essex M
    AIDS Res Hum Retroviruses; 2008 Jun; 24(6):827-37. PubMed ID: 18544018
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
    Jourdain G; Mary JY; Coeur SL; Ngo-Giang-Huong N; Yuthavisuthi P; Limtrakul A; Traisathit P; McIntosh K; Lallemant M;
    J Infect Dis; 2007 Dec; 196(11):1629-36. PubMed ID: 18008246
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differences in Breast Milk Composition of HIV-Infected and HIV-Uninfected Mothers of Premature Infants: Effects of Antiretroviral Therapy.
    Fouché C; van Niekerk E; du Plessis LM
    Breastfeed Med; 2016 Nov; 11():455-460. PubMed ID: 27529566
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants.
    Rice ML; Zeldow B; Siberry GK; Purswani M; Malee K; Hoffman HJ; Frederick T; Buchanan A; Sirois PA; Allison SM; Williams PL;
    Pediatr Infect Dis J; 2013 Oct; 32(10):e406-13. PubMed ID: 24067563
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mother-to-child HIV-transmission prevention programs in a sub-Saharan African setting: The Gabonese experience.
    Mintsa-Ndong A; Ndong-Ella C; Boussougou RK; Busugu LM; Mba A; Agwambouet FA; Barro N; Djoba Siawaya JF
    Int J STD AIDS; 2018 Mar; 29(3):221-226. PubMed ID: 28758568
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
    Newell ML; Borja MC; Peckham C;
    Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
    Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
    Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.
    Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O
    J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.